July 20, 2026 - 03:09

Micron Technology (MU) has finalized a series of long-term Strategic Customer Agreements with major automotive suppliers, including Qualcomm, Visteon, HARMAN, JOYNEXT, DENSO, Astemo, and Hyundai Mobis. These deals are designed to secure a steady supply of memory and storage components for the automotive sector, a market that is increasingly reliant on advanced chips for electric vehicles and autonomous driving systems.
Despite this positive development, Micron's stock has experienced a notable decline. The recent pullback appears to be part of a broader profit-taking trend affecting AI-related chip stocks. Over the past seven days, the share price has dropped by 13.31%. This raises the question of whether the selloff is overdone and if the current price presents a buying opportunity for long-term investors.
The automotive agreements signal strong demand for Micron's products outside of the volatile consumer electronics market. By locking in contracts with key industry players, the company is diversifying its revenue streams. However, the market's immediate reaction suggests that short-term sentiment is still heavily tied to the AI sector's momentum. For investors focused on fundamentals, the pullback might be a chance to enter at a lower valuation, but the broader market volatility remains a factor to watch.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...